Skip to main content

and
  1. Article

    Open Access

    Immunotherapies for pediatric cancer: current landscape and future perspectives

    The advent of immunotherapy has revolutionized how we manage and treat cancer. While the majority of immunotherapy-related studies performed to date have focused on adult malignancies, a handful of these thera...

    Brian Hutzen, Siddhi Nath Paudel, Meisam Naeimi Kararoudi in Cancer and Metastasis Reviews (2019)

  2. Article

    Open Access

    Cooperation of Oncolytic Herpes Virotherapy and PD-1 Blockade in Murine Rhabdomyosarcoma Models

    Oncolytic virotherapy is an effective immunotherapeutic approach for cancer treatment via a multistep process including direct tumor cell lysis, induction of cytotoxic or apoptosis-sensitizing cytokines and pr...

    Chun-Yu Chen, Pin-Yi Wang, Brian Hutzen, Les Sprague, Hayley M. Swain in Scientific Reports (2017)

  3. Article

    Open Access

    Treatment of medulloblastoma with oncolytic measles viruses expressing the angiogenesis inhibitors endostatin and angiostatin

    Medulloblastoma is the most common type of pediatric brain tumor. Although numerous factors influence patient survival rates, more than 30% of all cases will ultimately be refractory to conventional therapies....

    Brian Hutzen, Hemant Kumar Bid, Peter J Houghton, Christopher R Pierson in BMC Cancer (2014)

  4. Article

    Open Access

    Treatment of medulloblastoma using an oncolytic measles virus encoding the thyroidal sodium iodide symporter shows enhanced efficacy with radioiodine

    Medulloblastoma is the most common malignant brain tumor of childhood. Although the clinical outcome for medulloblastoma patients has improved significantly, children afflicted with the disease frequently suff...

    Brian Hutzen, Christopher R Pierson, Stephen J Russell, Evanthia Galanis in BMC Cancer (2012)

  5. Article

    Open Access

    Dietary agent, benzyl isothiocyanate inhibits signal transducer and activator of transcription 3 phosphorylation and collaborates with sulforaphane in the growth suppression of PANC-1 cancer cells

    The Signal Transducer and Activator of Transcription (STAT) proteins comprise a family of latent transcription factors with diverse functions. STAT3 has well established roles in cell proliferation, growth and...

    Brian Hutzen, William Willis, Sarah Jones, Ling Cen in Cancer Cell International (2009)

  6. Article

    Open Access

    New structural analogues of curcumin exhibit potent growth suppressive activity in human colorectal carcinoma cells

    Colorectal carcinoma is one of the major causes of morbidity and mortality in the Western World. Novel therapeutic approaches are needed for colorectal carcinoma. Curcumin, the active component and yellow pigm...

    Ling Cen, Brian Hutzen, Sarah Ball, Stephanie DeAngelis, Chun-Liang Chen in BMC Cancer (2009)

  7. Article

    Open Access

    STAT3 can be activated through paracrine signaling in breast epithelial cells

    Many cancers, including breast cancer, have been identified with increased levels of phosphorylated or the active form of Signal Transducers and Activators of Transcription 3 (STAT3) protein. However, whether ...

    Jacqueline C Lieblein, Sarah Ball, Brian Hutzen, A Kate Sasser, Huey-Jen Lin in BMC Cancer (2008)

  8. Article

    Open Access

    Signal transducer and activator of transcription 3 activation is associated with bladder cancer cell growth and survival

    Constitutive activation of signal transducer and activator of transcription 3 (Stat3) signaling pathway plays an important role in several human cancers. Activation of Stat3 is dependent on the phosphorylation...

    Chun-Liang Chen, Ling Cen, Jennifer Kohout, Brian Hutzen in Molecular Cancer (2008)